Internal Medicine-Neurology

【Growth Process】

History The Department of Neurology of Fuyang District First People's Hospital began to establish a neurology treatment team in the 1990s, and the neurology ward was established on March 18, 2008. After several generations of unremitting efforts, the department has reached the advanced level in Hangzhou in terms of comprehensive development of medical care, teaching, scientific research and other disciplines, and is now a key medical specialty in Fuyang District. In August 2000, the first minimally invasive treatment for cerebral hemorrhage was carried out. (Main developer: Shen Baoding) In November 2000, the first intravenous thrombolytic treatment of urokinase for cerebral infarction was carried out. (Main developer: Wang Hongxiang) In August 2005, the first case of repositioning treatment for positional vertigo was carried out. Main developer: Wang Hongxiang) On March 18, 2008, the hospital officially opened neurology specialty departments and outpatient clinics. In May 2013, the first case of electromyography and repetitive electrical stimulation technology was carried out. (Main developer: Wu Xiaoli) In July 2015, it was awarded the first batch of member units of the China Stroke Center Alliance. In July 2015, the first intravenous thrombolytic treatment with r-tpA was carried out. (Main developer: Wang Hongxiang) In November 2015, the first case of hyperbaric oxygen therapy for a stroke patient was carried out. (Main developer: Zhang Wen) In November 2017, the first clinical application of the vertigo diagnosis and treatment instrument was carried out. (Main developer: Wu Zhenxia) In October 2016, the first case of botulinum toxin treatment for dystonia (hemifacial spasm, blepharospasm, torticollis) was carried out. Main developers: Wang Jian, Chen Jian'e) In October 2017, the first cerebral angiography (DSA) technology was carried out. Main developer: Nie Dongliang) In October 2017, the first case of carotid artery stent implantation was carried out. (Main developer: Wang Jian) In October 2017, the first case of bridging thrombectomy technology for acute cerebral infarction was carried out. (Main developer: Wang Hongxiang) In November 2017, the department was awarded the district-level key discipline by the Fuyang District Health Commission. In April 2018, the first case of post-stroke cognitive dysfunction screening was carried out. (Main developer: Chen Xiaoping) In August 2018, the first case of video EEG and monitoring technology was carried out. (Main developer: Zhu Qianwen) In September 2018, a special disease clinic for high-risk screening of Parkinson's disease and cerebrovascular disease was opened. (Main developer: Wang Hongxiang) In March 2019, the first cerebrospinal fluid serum immunological test for autoimmune encephalitis was carried out. (Main performer: Chen Jian'e) In October 2019, the first case of internal carotid artery endarterectomy was performed. (Main developer: Qiu Shenzhong) In November 2019, it successfully passed the review and acceptance of the "Zhejiang Stroke Prevention and Control Center" and won the Excellence Award for Continuous Quality Improvement. In November 2019, the department won the Youth Civilization Award from the Fuyang District Committee of the Communist Youth League. In February 2020, the first anti-thrombotic drug gene test was carried out. (Main developer: Wang Xingnan) In May 2020, the first case of foot drop rehabilitation treatment was carried out. (Main developer: Zhang Jianmin) In May 2020, the first clinical application of TMS (transcranial magnetic stimulation therapy device) was carried out. (Main developer: Fang Yueying)

[Successively served as diagnosis and treatment team leader, director, and head nurse]

On March 18, 2008, under the leadership of department director Shen Baoding and head nurse Chen Xiaoping, Fuyang Ge Neurology Ward was established. In October 2014, department director Wang Hongxiang and head nurse Chen Xiaoping led the medical staff in the department to further improve the diagnosis and treatment standards of the discipline and launched a series of new technologies and new projects. The discipline has developed well and was awarded the title of Fuyang District Health Care Center in November 2017. The Health Bureau rated it as a key discipline in Fuyang District. During this period, the successive head nurses were: Chen Xiaoping in March 2008, and Yu Huaqin in April 2020. During this period, the successive deputy directors were: Wu Zhenxia in April 2016, and Chen Jian'e in July 2018.

【Current status of subject】

The Department of Neurology is the only department in Fuyang City that is responsible for acute cerebrovascular diseases, neurological infectious diseases, epilepsy, headaches, dizziness, dementia, peripheral nerve diseases, movement disorders, spinal cord diseases, muscle diseases, nervous system developmental abnormalities and genetic diseases. Specialized departments for medical treatment, teaching, scientific research and other work. It treats more than 2,200 inpatients and about 50,000 outpatients every year. At the same time, he also has certain experience in the diagnosis and treatment of common psychological and mental diseases such as anxiety, depression, neurasthenia, and sleep disorders. The Department of Neurology currently has 3 chief physicians, 2 deputy chief physicians, 3 attending physicians, 4 residents, and 3 with graduate degrees or above. 16 specialist nursing staff. There are 43 beds, and more than 51 beds are actually open. We also open expert and specialist clinics all year round (such as stroke, epilepsy, headache, dizziness, sleep disorders, dementia and various neurological disease clinics, etc.). The department continues to introduce advanced technology and will work with neurosurgery colleagues to create a brain center. The medical staff of the department are closely united around the department director and subject leader, chief physician Wang Hongxiang, and their good teamwork has enabled the Department of Neurology to be rated as the district-level youth civilization number of the Fuyang District Youth League Committee, the Zhejiang Provincial Stroke Prevention and Treatment Center, and the first group in the hospital skills competition. Prizes.

【Diagnosis and treatment scope】

Based on cerebrovascular disease and focusing on endovascular treatment, it comprehensively integrates headache, dizziness, Parkinson's disease, dementia, cognitive impairment, epilepsy, psychosomatic diseases and genetic testing technology, and meets the requirements of subject development, attaches great importance to scientific research and teaching, and strengthens mentoring and mentoring management. It will gradually be built into a regional cerebrovascular disease treatment center, epilepsy diagnosis and treatment center, and brain department center.

【Technical Features】

The department's existing supporting equipment includes: MRI, 64-slice CT, video electroencephalogram monitoring system, electromyography, TCD and large PHILIPS digital subtraction angiography equipment DSA, etc. The department has published more than 40 papers in various medical and health journals, and has carried out new technologies and projects: ① intravenous thrombolytic treatment for acute cerebral infarction ② technological innovation in sports rehabilitation, speech rehabilitation, swallowing function, mental and psychological rehabilitation and asphyxia prevention, TMS Transcranial magnetic stimulation technology, neurorehabilitation treatment of brain dysfunction treatment equipment ③ Mild hypothermia cerebral protection therapy, intracranial pressure monitoring ④ TCD detection of intracranial vascular stenosis and microemboli ⑤ Electromyography, auditory visual somatosensory visual evoked potential ⑥ Sleep , dementia, Parkinson's specialist outpatient clinic ⑦ Interventional diagnosis and treatment technology of cerebral blood vessels ⑧ Manual reduction treatment of BPPV ⑨ Botulinum toxin treatment of hemifacial spasm, etc. As of May 2020, there have been more than 300 cases of r-tpA intravenous thrombolysis and more than 100 cases of botulinum toxin treatment. More than 50 cases of EEG monitoring, nearly 100 cases of cerebral angiography, 8 cases of stent implantation, 4 cases of bridging thrombectomy, and 2 cases of carotid endarterectomy. The department routinely performs disease severity assessment scale scores, including GCS score for level of consciousness, NIHSS score for neurological deficit, ESSEN score for stroke recurrence risk, Kubota drinking test assessment for swallowing function, DVT score for deep vein thrombosis, and TIA. ABCD2 score for recurrence risk, CHA2DS2-VASc score for atrial fibrillation anticoagulation therapy and HAS-BLED score for bleeding risk, ASPECTS score before thrombolysis treatment and HAT score for thrombolysis-hemorrhagic transformation risk, etc.

【Scientific research results】

The department has a scientific research and clinical workstation for Dr. Run Run Shaw. As an affiliated hospital of Zhejiang University of Traditional Chinese Medicine, our department undertakes the clinical teaching tasks of this major and implements teaching and clinical internship and internship teaching. Established and completed 3 provincial and municipal level projects, reaching the advanced level in the province. Successfully held 2 provincial and municipal continuing education classes and published nearly 40 papers, including nearly 10 Chinese SCI articles.